Parnax Lab

Parnax Lab EPS Growth

The EPS Growth of Parnax Lab (506128.BO) as of Oct 29, 2026 is 19.87 %. In the previous year, EPS Growth was 7.46 % — a change of 166.55% (higher).

EPS Growth

19.87 %

YoY

166.55%

Last updated:

EPS Growth of Parnax Lab is 2025 19.87 % . EPS Growth of Parnax Lab was 2024 7.46 % . It decreases by 166.55% higher compared to the previous year.

The Parnax Lab EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2018
-71.40 INR
Jan 1, 2019
213.03 INR
Jan 1, 2020
-188.34 INR
Jan 1, 2021
87.51 INR
Jan 1, 2022
2,362.57 INR
Jan 1, 2023
-19.60 INR
Jan 1, 2024
7.46 INR
Jan 1, 2025
19.87 INR
The Parnax Lab EPS Growth history
YEAREPS GrowthYoY
19.87 %+166.55%
7.46 %-138.04%
-19.60 %-100.83%
2,362.57 %+2,599.79%
87.51 %-146.46%
-188.34 %-188.41%
213.03 %-398.37%
-71.40 %-252.15%
46.93 %-214.19%
-41.09 %-158.01%
70.84 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

EPS Growth of Parnax Lab is 19.87 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Parnax Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Parnax Lab

All Key Metrics — Parnax Lab